Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What Risks and Opportunities Define Aptamer Group?

As demand for innovative biological tools continues to increase, Aptamer Group is seeking to expand its commercial footprint through strategic partnerships, licensing opportunities and product development.

Ishan Mudgal | 26 June 2026

Can Verici Dx plc Expand Its Presence in Molecular Diagnostics?

As healthcare systems increasingly adopt precision medicine, demand for diagnostic tools capable of delivering personalized insights continues to grow. Verici Dx operates in this expanding segment by developing tests that aim to improve transplant outcomes, reduce complications, and support more efficient use of healthcare …

Ishan Mudgal | 26 June 2026

FDBK Shares Flash Oversold Signal: Is Feedback plc Too Cheap After Market Pressure?

Feedback (FDBK) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a medical imaging and clinical data technology company, …

Divya Sood | 26 June 2026

EDX Shares Fall: Is EDX Medical Now an Oversold Healthcare Watch?

EDX Medical Group (EDX) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a diagnostics and precision-medicine company, its …

Divya Sood | 26 June 2026

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions